Evidence map›Paper›PMID 35693016›Full record

ArticleFrontiers in neurology2022

Case Report: Presence of Anti-MAG in the CSF Can Be Associated With a Neurodegenerative Process With Frontal Involvement.

Guillaume Dorcet, Marie Benaiteau, Fabienne Ory-Magne, Antoine Blancher, Jérémie Pariente, Françoise Fortenfant, Chloé Bost

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Guillaume DorcetDépartement de Neurologie, Hôpital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France.
Marie BenaiteauDépartement de Neurologie, Hôpital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France.
Fabienne Ory-MagneDépartement de Neurologie, Hôpital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France.
Antoine BlancherINSERM U1043 - CNRS UMR 5282, INFINITY, Toulouse, France.
Jérémie ParienteDépartement de Neurologie, Hôpital Pierre Paul Riquet, CHU de Toulouse, Toulouse, France.
Françoise FortenfantLaboratoire d'Immunologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
Chloé BostINSERM U1043 - CNRS UMR 5282, INFINITY, Toulouse, France.
Centre Hospitalier Universitaire de Toulouse · FRHôpital Paule de Viguier · FRInstitut Toulousain des Maladies Infectieuses et InflammatoiresInstitut de Pharmacologie et de Biologie Structurale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Autoimmune encephalitis (AIE) is an increasingly broad nosological framework that may clinically mimic neurodegenerative diseases (NDDs). Cases Reported: We describe here the clinical, radiological, electrophysiological, and biological evolution of three patients. Two women aged 73 and 72 years and a 69-year-old man presented with complex cognitive and focal neurological symptoms and each had a predominant frontal dysexecutive involvement and an unexpectedly high titer of anti-MAG antibodies in the serum and cerebrospinal fluid (CSF). The question of an autoimmune cause was raised. After 2 years of follow-up and, for two of them, without improvement despite immunosuppressive treatments, diagnoses of NDD were eventually retained: post-radiation encephalopathy, progressive supranuclear palsy (PSP), and Alzheimer's disease. Conclusion: The presence of a high titer of anti-MAG antibodies may be found in NDD. It could reflect cerebral tissue damages, particularly in the case of significant frontal involvement. Atypical presentations may lead to a search for a paraneoplastic neurologic syndrome or AIE. However, the indirect immunofluorescence staining positivity on a monkey cerebellum section linked with anti-MAG antibodies should not lead to those diagnoses being retained.

Indexed as

autoantibodiesdifferential diagnosisMAGmyelin alterationneurodegenerative diseases

Identifiers

PMID35693016
PMCPMC9176167
OpenAlexW4281491631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.